By E-commerce 4 Internet Marketers Editorial
Listicle. Website owners and developers who sell nicotine pouches and other tobacco alternatives online sit at the intersection of U.S. Food and Drug Administration (FDA) tobacco authorities, Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) Prevent All Cigarette Trafficking (PACT) Act delivery-sale rules when those rules apply to a SKU, United States Postal Service (USPS) mailing limits for covered tobacco categories, and payment-platform acceptable-use lists. Fast-growing oral nicotine catalogs often inherit cigarette-era remote-sale and acquiring constraints even when the product looks like a modern pouch rather than a carton of cigarettes. This twelve-check listicle is a storefront and fulfillment QA plan built only from public primary materials. It is not legal, tax, shipping, licensing, or underwriting advice. Do not invent FDA classifications, marketing authorizations, or state remote-sale bans. Where a destination statute or a product-classification question cannot be verified from a primary source, block the SKU or the ship-to until counsel or compliance staff confirm eligibility.
1. Confirm every catalog SKU has an FDA marketing order, or treat it as unauthorized
FDA’s Tobacco Products Marketing Orders page states that to legally market a new tobacco product in the United States, a company must receive a written marketing order from FDA through one of three pathways (Premarket Tobacco Product Application (PMTA), Substantial Equivalence (SE), or Exemption from Substantial Equivalence (EX REQ)). New tobacco products that lack authorization, including products covered by a marketing denial order (MDO), cannot be legally introduced into interstate commerce, and FDA states that sale or distribution is subject to administrative, civil, and criminal enforcement. FDA also states it intends to ensure compliance by distributors and retailers, not only manufacturers.
Check: for each nicotine pouch or tobacco-alternative SKU, record the marketing granted order (MGO) citation or an explicit “unauthorized / do not sell” flag before the product can enter the cart.
2. Separate tobacco-derived nicotine from non-tobacco nicotine (NTN)
FDA’s Regulation and Enforcement of Non-Tobacco Nicotine (NTN) Products page explains that NTN is nicotine that did not come from a tobacco plant (including synthetic nicotine). A federal law effective April 14, 2022 clarified FDA authority over tobacco products containing nicotine from any source. FDA states that NTN products can only be legally marketed in the United States if they received premarket authorization, and that (as of that page’s content) no NTN products have received marketing authorizations. A pending or accepted application is not authorization.
Check: tag every SKU with nicotine source (`tobacco_derived` vs `ntn` vs `unknown`). Refuse `unknown` and refuse NTN SKUs that lack a written FDA marketing order.
3. Match live SKUs to FDA's authorized nicotine pouch list and searchable database
FDA publishes a dedicated Nicotine Pouch Products Authorized by the FDA page and states that the listed products are the only nicotine pouch products that may be lawfully sold in the United States. As fetched for this draft, FDA reported 43 authorized nicotine pouch products across Helix Innovations LLC (on! and on! PLUS) and Swedish Match USA, Inc. (ZYN and ZYN ULTRA strengths and flavors on that table). FDA also points operators to its Searchable Tobacco Products Database hub resources as the broader listing of tobacco products that can be legally marketed. Authorizations are product-specific. FDA’s January 16, 2025 ZYN announcement stressed that those actions applied only to the named products and strengths, not to other nicotine pouches or other ZYN products, and did not authorize reduced-risk claims.
Check: reconcile catalog SKUs against the authorized pouch page and the searchable database by manufacturer, product name, and nicotine strength. Do not sell “sibling” flavors or strengths that are not on the authorized list.
4. Do not confuse FDA enforcement-priority guidance with a marketing order
On May 8, 2026, FDA announced guidance on enforcement priorities for certain ENDS and nicotine pouch products marketed without premarket authorization. FDA described situations in which it does not intend to prioritize enforcement (for example, certain pending accepted and filed applications, with additional caveats for non-tobacco-flavored ENDS data and youth-appealing product features). FDA expressly stated that falling within an enforcement policy has no bearing on whether a product is likely to receive premarket authorization. For ecommerce operators, “deprioritized enforcement” is not a green-light license to list a product as authorized.
Check: storefront copy and compliance flags must distinguish `mgo_authorized`, `pending_application_only`, and `unauthorized`. Only `mgo_authorized` should be sellable unless counsel documents a different, written legal basis.
5. Encode Tobacco 21 as a hard cart rule for every tobacco product, including non-tobacco nicotine
FDA’s Tobacco 21 page states that since December 20, 2019 it has been illegal for a retailer to sell any tobacco product, including e-cigarettes, to anyone under 21, with no federal carve-out for military personnel ages 18 to 20. FDA also states it is unlawful to sell a tobacco product containing nicotine from any source, including non-tobacco nicotine, to any person younger than 21. Beginning September 30, 2024, under FDA’s final rule described on that page, retailers must use a photo ID to verify the age of anyone under 30 trying to purchase cigarettes, smokeless tobacco, and covered tobacco products. 21 CFR 1140.14 likewise bars retailer sales of cigarettes, smokeless tobacco, and covered tobacco products to persons younger than 21 and requires photographic identification verification except for persons over age 29.
Check: require date-of-birth capture plus documented photo-ID verification for purchasers who are not over 29 before payment authorization. Fail closed for guests who skip verification.
6. Treat remote age and identity verification as a product requirement, not a banner
Mail-order sales of cigarettes and smokeless tobacco are contemplated as an exception to face-to-face-only sales in 21 CFR 1140.16(c), but age and identification duties still apply. FDA’s Tobacco 21 materials state that FDA inspects brick-and-mortar and online retailers for sale and distribution compliance. For authorized nicotine pouch marketing, FDA’s January 16, 2025 ZYN announcement described stringent digital, TV, and radio marketing restrictions aimed at adults 21 and older, including audience targeting and measurement obligations on the manufacturer. Ecommerce teams should assume adult-only site access, checkout identity checks, and advertising audience controls are part of the same compliance stack even when a particular MGO letter is not pasted into the theme footer.
Check: gate the catalog behind an age affirmation that is not a single click-through for purchasers who must show ID, wire an independent age/identity provider into checkout, and keep logs for compliance audits.
7. Put the required nicotine addiction warning on packages and on website ads
Under 21 CFR 1143.3, packages and advertisements for cigarette tobacco, roll-your-own tobacco, and covered tobacco products other than cigars must bear: “WARNING: This product contains nicotine. Nicotine is an addictive chemical.” For visual advertisements (FDA and the regulation expressly include web pages and email), the warning must occupy at least 20 percent of the advertisement area, meet font and contrast rules, and sit in a rectangular border. FDA’s Advertising and Promotion page restates those advertisement format requirements. Retailers who display public ads without a required warning, or who materially alter a warning, can face liability under the regulation’s retailer provisions.
Check: product detail pages, collection ads, paid landing pages, and promotional emails that advertise covered products must include a compliant warning block, not a tiny footer disclaimer.
8. Strip modified-risk, "light," "mild," and "low" claims unless an MRTP order exists
FDA’s Advertising and Promotion page states that for deemed products, manufacturing of products whose label, labeling, or advertising uses the descriptors “light,” “mild,” “low,” or similar descriptors had to stop by November 8, 2017 unless a Modified Risk Tobacco Product (MRTP) order was in effect (with a December 8, 2017 interstate distribution cutoff described there). For other deemed modified-risk tobacco products, introduction into interstate commerce without an MRTP order was barred as of the deeming rule effective date (August 8, 2016). FDA’s ZYN authorization announcement expressly stated the authorization did not allow reduced-risk claims, which would require a separate MRTP application.
Check: scan PDP copy, comparison tables, influencer briefs, and meta titles for cessation, “safer than,” “light,” “mild,” “low,” or similar claims. Remove anything not backed by a current MRTP order for that exact product.
9. Block free samples and youth-appealing promotions in the storefront
21 CFR 1140.16(d) generally prohibits manufacturers, distributors, and retailers from distributing free samples of cigarettes, smokeless tobacco, or other tobacco products, with a narrow smokeless-tobacco exception limited to qualified adult-only facilities and quantity caps. FDA’s Advertising and Promotion page states the free-sample prohibition applies to all tobacco products (with that smokeless qualified-facility exception). FDA’s May 8, 2026 enforcement-priorities announcement also flags presumptively underage-appealing elements such as cartoon-like fictional characters, products that disguise their nature, or products resembling children’s toys, phones, or gaming platforms as factors that can pull a product out of deprioritized enforcement.
Check: disable “free pouch with signup,” mystery-sample kits, and cartoon/toy-like creative on DTC properties. Treat sample SKUs as non-sellable unless counsel confirms a lawful exception that actually fits the product and channel.
10. Determine whether PACT Act delivery-sale duties apply to each SKU before coding shipping
ATF’s PACT Act materials (as summarized in ATF public pages indexed for this draft) require persons who sell, transfer, ship, or advertise cigarettes (including electronic nicotine delivery systems (ENDS) after the 2021 statutory expansion) or smokeless tobacco in interstate commerce into taxing jurisdictions to register with ATF and with destination tobacco tax administrators, file required reports, and comply with state, local, and tribal licensing and tax laws. Delivery sellers face additional labeling, recordkeeping, age, tax, and package rules under 15 U.S.C. § 376a, including a clear package statement about excise taxes and licensing obligations, a generally applicable under-10-pound shipment limit for individual delivery sales, advance tax payment and stamping where required, and record retention through the end of the fourth full calendar year after the sale (per ATF’s tobacco sellers reporting page content indexed for this draft).
Critical classification note for pouch brands: USPS Publication 52 section 471 defines “smokeless tobacco” as finely cut, ground, powdered, or leaf tobacco intended for oral or nasal use without combustion, and defines ENDS as aerosolizing electronic devices and their components or liquids. Many modern nicotine pouches do not match those USPS “covered product” definitions on their face. FDA scientific review materials for authorized ZYN products have also described those pouches as not smokeless tobacco products because they do not consist of cut, ground, powdered, or leaf tobacco. This article does not invent a universal rule that every nicotine pouch is or is not a PACT Act “smokeless tobacco” article. Composition (tobacco-derived vs synthetic, presence of tobacco leaf material, and how the SKU is taxed and offered) can change the analysis.
Check: for each SKU, obtain a documented classification answer (PACT-covered cigarette/ENDS/smokeless vs not covered) from counsel or a primary ATF/statutory reading tied to that product. If covered, complete ATF and destination-state registration and reporting before the first interstate sale. If not covered, still map destination age, licensing, and tax rules that apply under other law. Never hard-code “pouches are exempt nationwide” as a cart constant.
11. Encode carrier choice, adult delivery, and destination remote-sale blocks without inventing state bans
USPS Publication 52 section 472 states that cigarettes, smokeless tobacco, and ENDS “covered products” are generally nonmailable unless a listed exception and its conditions apply. The Postal Service will not accept, forward, or deliver packages it knows or reasonably believes contain nonmailable covered products, and nonmailable covered products are subject to seizure and forfeiture. Private carriers publish separate adult-signature and restricted-item rules. Separately, when PACT Act delivery-sale rules apply, ATF materials state remote sales must comply with destination state and local laws as if the sale occurred entirely in that place, including licensing, minor-sale restrictions, taxes, and remote or flavored-product limits where those laws exist.
This draft deliberately does not list which states ban remote nicotine pouch or tobacco-alternative sales. Those matrices change and must be verified from primary state sources or counsel memos tied to named statutes.
Check: build a destination matrix with fields such as `remote_sale_status` (allowed, banned, unknown), `carrier_ok` flags, `adult_signature_required`, and `last_verified_at`. Hard-fail `unknown` and `banned`. Prefer private-carrier adult-signature services when counsel confirms a SKU is not USPS-mailable or when delivery-sale rules require in-person adult receipt. Do not invent a state ban row from a blog post.
12. Align payment rails and platform policies with the disclosed tobacco catalog
Public processor and platform rules treat tobacco and nicotine products as prohibited or restricted even when a SKU is FDA-authorized.
- Stripe’s Prohibited and Restricted Businesses list (last updated 2026-05-13 as fetched) places tobacco products, including e-cigarettes, cigars, and e-liquid sold in accordance with applicable law, plus herbal and vitamin e-cigarettes and cigarettes, and production equipment marketed for tobacco products, in the restricted due-diligence category (not a self-serve guarantee).
- PayPal’s Acceptable Use Policy prohibits transactions involving cigarettes and lists non-cigarette tobacco products, e-cigarettes, and cigars among activities requiring pre-approval.
- Shopify Payments eligibility guidance lists tobacco and related products among regulated products Shopify Payments cannot support.
Check: disclose the full nicotine or tobacco catalog to the acquirer, confirm MCC and acceptable-use fit in writing, and keep age-gate, authorization, and shipping evidence in the underwriting packet. Do not route tobacco volume through a mainstream MID that publicly prohibits or restricts the category without approval. Authorization from FDA does not rewrite Stripe, PayPal, or Shopify Payments contracts.
What this checklist deliberately omits
- Invented state-by-state remote-sale ban tables for nicotine pouches or other oral nicotine products.
- A blanket claim that all nicotine pouches are PACT Act “smokeless tobacco” or that all are outside PACT.
- Claims that FDA “approved” authorized pouches as safe (FDA states authorized products are not “FDA approved” and are not safe).
- Invented counts of authorized SKUs beyond FDA’s authorized-pouch page figure fetched for this draft (43 products on that page at fetch time).
- Carrier rate cards, adult-signature fee schedules, or payment MCC codes presented as universal law.
Those omissions protect operators from false certainty. The North Star for this site is website owners and developers selling regulated products. Their cart, CMS, warehouse, and acquiring stack need maintainable flags fed by FDA orders, age-verification evidence, PACT and carrier classifications verified per SKU, and processor contracts, not a static article pretending to be a 51-jurisdiction statute digest.
Sources
- FDA Tobacco Products hub
- FDA Tobacco Products Marketing Orders
- FDA Nicotine Pouch Products Authorized by the FDA
- FDA ZYN marketing authorization announcement (January 16, 2025)
- FDA NTN regulation and enforcement
- FDA enforcement priorities for unauthorized ENDS and nicotine pouches (May 8, 2026)
- FDA Tobacco 21